ALFIERI, SILVIA
ALFIERI, SILVIA
DIPARTIMENTO DI STUDI INTERNAZIONALI (attivo dal 01/01/1999 al 27/04/2012)
Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide in head and neck cancer: the CONFRONT phase I-II trial
2025 M.C. Merlano, N. Denaro, M. Paccagnella, A. Abbona, D. Galizia, S. Alfieri, C. Bergamini, E. Orlandi, A.M. Merlotti, S. Bondi, L. Licitra, O. Garrone
The role of volumetry in sinonasal cancer response assessment to induction chemotherapy, results from two phase II non-randomized controlled prospective multicentric trials: SINTART-1 and SINTART-2
2025 P. Rondi, D. Mattavelli, V. Rampinelli, A. Schreiber, E. Orlandi, B. Vischioni, N.A. Iacovelli, G. Calareso, C. Bergamini, S. Alfieri, P. Castelnuovo, P. Battaglia, M. Turri-Zanoni, P. Nicolai, M. Ferrari, L. Licitra, P. Bossi, D. Farina, M. Ravanelli, C. Resteghini
The Tumor Microenvironment and the Estrogen Loop in Thyroid Cancer
2023 N. Denaro, R. Romano, S. Alfieri, A. Dolci, L. Licitra, I. Nuzzolese, M. Ghidini, C. Bareggi, V. Bertaglia, C. Solinas, O. Garrone
Corrigendum: “Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma” (European Journal of Cancer (2021) 157 (250–258)
2022 A. Baggi, P. Quaglino, M. Rubatto, R. Depenni, M. Guida, P.A. Ascierto, C. Trojaniello, P. Queirolo, M. Saponara, K. Peris, F. Spagnolo, L. Bianchi, F. De Galitiis, M.C. Potenza, I. Proietti, R. Marconcini, A. Botticelli, V. Barbieri, L. Licitra, S. Alfieri, C. Ficorella, A. Cortellini, M.C. Fargnoli, T. Troiani, L. Tondulli, M. Zamparini, P. Bossi
The appropriate use of circulating EBV-DNA in nasopharyngeal carcinoma: Comprehensive clinical practice guidelines evaluation
2021 C. Trevisiol, M. Gion, A. Vaona, A.S.C. Fabricio, E. Roca, L. Licitra, S. Alfieri, P. Bossi
Monitoring patients with head and neck cancer for flu-like symptoms during the COVID-19 pandemic
2021 S. Cavalieri, E. Colombo, A. Bottiglieri, G. Massa, F. Platini, A. Ottini, D. Filippini, E. Zattarin, C. Bergamini, C. Resteghini, S. Alfieri, V. Di Martino, V. Tiraferri, L. Locati, L. Licitra
A randomized, double-blind, placebo-controlled, cross-over study to evaluate the efficacy of Aqualief™ mucoadhesive tablets in head and neck cancer patients who developed radiation-induced xerostomia
2021 N.A. Iacovelli, R. Ingargiola, N. Facchinetti, M. Franceschini, D.A. Romanello, P. Bossi, C. Bergamini, S. Alfieri, S. Cavalieri, G. Baron, G. Aldini, L. Locati, E. Orlandi
A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients
2020 R. Ingargiola, M. De Santis, N. Iacovelli, N. Facchinetti, A. Cavallo, E. Ivaldi, M. Dispinzieri, M. Franceschini, C. Giandini, D. Romanello, S. Di Biaso, M. Sabetti, L. Locati, S. Alfieri, P. Bossi, M. Guglielmo, F. Macchi, L. Lozza, R. Valdagni, C. Fallai, E. Pignoli, E. Orlandi
Fear of cancer recurrence in haematological cancer patients: exploring socio-demographic, psychological, existential and disease-related factors
2020 C. Borreani, S. Alfieri, L. Farina, E. Bianchi, P. Corradini
Role of IMRT/VMAT-Based Dose and Volume Parameters in Predicting 5-Year Local Control and Survival in Nasopharyngeal Cancer Patients
2020 N.A. Iacovelli, A. Cicchetti, A. Cavallo, S. Alfieri, L. Locati, E. Ivaldi, R. Ingargiola, D.A. Romanello, P. Bossi, S. Cavalieri, C. Tenconi, S. Meroni, G. Calareso, M. Guzzo, C. Piazza, L. Licitra, E. Pignoli, F. Carlo, E. Orlandi
Baseline mri-radiomics can predict overall survival in non-endemic ebv-related nasopharyngeal carcinoma patients
2020 M. Bologna, V. Corino, G. Calareso, C. Tenconi, S. Alfieri, N.A. Iacovelli, A. Cavallo, S. Cavalieri, L. Locati, P. Bossi, D.A. Romanello, R. Ingargiola, T. Rancati, E. Pignoli, S. Sdao, M. Pecorilla, N. Facchinetti, A. Trama, L. Licitra, L. Mainardi, E. Orlandi
PD-L1 Expression in Unresectable Locally Advanced or Metastatic Skin Squamous Cell Carcinoma Treated with Anti-Epidermal Growth Factor Receptor Agents
2019 S. Cavalieri, F. Perrone, M. Milione, A. Bianco, S. Alfieri, L.D. Locati, C. Bergamini, C. Resteghini, D. Galbiati, F. Platini, L. Licitra, P. Bossi